May 2, 2016 | Research News
Diagnosing mononucleosis: UGA’s Mark Ebell works to expedite proper treatment
The University of Georgia's Mark Ebell wasn't impressed with research on infectious mononucleosis when he wrote his first published review on it back in the 1990s. He still isn't—a subject he discusses in the April issue of the Journal of the American Medical Association.
April 14, 2016 | General News
UGA researchers working on Zika vaccine, can comment on virus
The Centers for Disease Control and Prevention has found that the Zika virus causes birth defects. Experts at the University of Georgia are available to comment on: • Their work to develop a Zika vaccine.• When Zika will come to the U.S.• The search for a vaccine and questions and answers about the virus.
March 29, 2016 | Research News
UGA, Sanofi Pasteur develop new vaccine for H1N1 influenza
Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models. They published their findings recently in the Journal of Virology.
February 3, 2016 | Research News
University of Georgia to collaborate with GeoVax on Zika vaccine
The University of Georgia announced today that it has entered into a collaborative research agreement with GeoVax Labs Inc. to develop and test a vaccine to prevent the emerging and virulent Zika virus infection.
January 4, 2016 | Research News
New model uses public health statistics to signal when disease elimination is imminent
Ecologists at the University of Georgia have developed a model showing that public health surveillance data can be used to signal when a disease is approaching eradication. Their research, just published in Theoretical Ecology, lays the groundwork for a potential new tool in the fight against infectious diseases.
December 23, 2015 | Research News
Study looks at reasons for delayed tuberculosis diagnosis in Uganda
Most studies of delayed tuberculosis diagnosis focus on the adverse effect of time elapsed between the onset of symptoms to reaching diagnosis and subsequent patient outcomes and control of community transmission.
December 2, 2015 | General News
UGA’s new Center for Molecular Medicine celebrated with groundbreaking
The University of Georgia broke ground Dec. 1 on the Center for Molecular Medicine, a 43,000-square-foot facility that will continue to advance UGA's efforts in human health research.
November 25, 2015 | Research News
Researchers assess use of drug-susceptible parasites to fight drug resistance
Researchers at the University of Georgia have developed a model for evaluating a potential new strategy in the fight against drug-resistant diseases.
November 17, 2015 | Research News
Vitamin D deficiency may limit immune recovery in HIV-positive adults
A University of Georgia researcher has found that low levels of vitamin D may limit the effectiveness of HIV treatment in adults.
November 10, 2015 | Research News
UGA receives $1.49 million grant for HIV, TB research training in Uganda
Every year, 50,000 people die in East Africa from tuberculosis. Worldwide, 1.5 million people die from the disease. And when HIV infection is added to the mix, TB becomes even more deadly. The University of Georgia is fighting against these numbers with a new $1.49 million grant from the Fogarty International Center of the National Institutes of Health.
November 5, 2015 | Research News
Study finds 75 percent of first-time moms plan to follow vaccine schedule
First-time expectant mothers who do not plan to follow the recommended childhood immunization schedule differ in a number of ways from mothers who do, according to a recent study led by the Centers for Disease Control and Prevention and the University of Georgia.
November 5, 2015 | Research News
Researchers identify essential component of antiviral defense
Infectious disease researchers at the University of Georgia have identified a signaling protein critical for host defense against influenza infection. The findings, recently published in PLoS Pathogens, shed light on how a single component of the body's defense system promotes effective immunity against viral infections—particularly respiratory viruses—that affect mucosal sites.
November 2, 2015 | Research News
UGA researcher receives $1 million for cryptosporidium research
Researchers at the University of Georgia have received $1 million from the Wellcome Trust and the Bill & Melinda Gates Foundation to speed the development of new drugs for the treatment of cryptosporidiosis, a major cause of diarrheal disease and mortality in young children around the world.
September 4, 2015 | Research News
UGA microbiologists describe new insights into human neurodegenerative disease
Microbiology researchers at the University of Georgia studying a soil bacterium have identified a potential mechanism for neurodegenerative diseases.
August 13, 2015 | Research News
UGA receives $1.25 million for training of tropical, emerging global diseases researchers
The University of Georgia's Center for Tropical and Emerging Global Diseases was awarded $1.25 million by the National Institutes of Health to continue training graduate and postdoctoral students over the next five years who can help address the growing threats of parasitic diseases.